郑重说明:

您值得信赖的中药成分及标准合作伙伴满足您研发和工业化需求

产品关键词：香草酸-4-β-D-葡萄糖苷 6-甲氧基山奈酚茯苓新酸B 去甲异波尔定

guanyuwomen关于德思特

联系方式

服务热线：

028-8500-3950

公司传真：	028-85589956
公司邮箱：	sales@tcmlmt.com
公司网址：	www.028desite.com
公司地址：	四川省成都市温江区海科路西段128号5栋

发表文献展示

当前位置:首页关于德思特 > 发表文献展示 >

Molecules-13 December 2019 黄连碱表小檗碱

时间：2020-09-03 浏览次数：分享到：

Synergistic Inhibition of Acetylcholinesterase by Alkaloids Derived from Stephaniae Tetrandrae Radix, Coptidis Rhizoma and Phellodendri Chinensis Cortex

期刊名：Molecule
文献编号：doi.org/10.3390/molecules24244567
文献地址：https://www.mdpi.com/1420-3049/24/24/4567
发表日期：13 December 2019

Abstract
Alkaloids having acetylcholinesterase (AChE) inhibitory activity are commonly found in traditional Chinese medicine (TCM); for example, berberine from Coptis chinensis, galantamine from Lycoris radiata, and huperzine A from Huperzia serrata. In practice of TCM, Stephaniae Tetrandrae Radix (STR) is often combined with Coptidis Rhizoma (CR) or Phellodendri Chinensis Cortex (PCC) as paired herbs during clinical application. Fangchinoline from STR and coptisine and/or berberine from CR and/or PCC are active alkaloids in inhibiting AChE. The traditional usage of paired herbs suggests the synergistic effect of fangchinoline–coptisine or fangchinoline–berberine pairing in AChE inhibition. HPLC was applied to identify the main components in herbal extracts of STR, CR, and PCC, and the AChE inhibition of their main components was determined by Ellman assay. The synergism of herb combination and active component combination was calculated by median-effect principle. Molecular docking was applied to investigate the underlying binding mechanisms of the active components with the AChE protein. It was found that fangchinoline showed AChE inhibitory potency; furthermore, fangchinoline–coptisine/berberine pairs (at ratios of 1:5, 1:2, 1:1, and 2:1) synergistically inhibited AChE; the combination index (CI) at different ratios was less than one when Fa = 0.5, suggesting synergistic inhibition of AChE. Furthermore, the molecular docking simulation supported this enzymatic inhibition. Therefore, fangchinoline–coptisine/berberine pairs, or their parental herbal mixtures, may potentially be developed as a possible therapeutic strategy for Alzheimer’s patients.
Keywords: acetylcholinesterase; fangchinoline; coptisine; berberine; synergistic effect

coptisine (Lot DST170711-003,purity 99%) and epiberberine (Lot DST170711-109, purity 99%) were purchased from from Chengdu Desite Biological Technology Co. Ltd. (Sichuan, China).

上一篇：Acta Pharmaceutica Sinica B-6 May 2020 雷公藤甲素 38748-32-2

下一篇：Molecules-20 January 2020 白杨素芹菜素香叶木素山奈酚-7-O-葡萄